Elekta’s MOSAIQ® version 2.20 now includes an interface to Xstrahl’s superficial and orthovoltage radiotherapy systems, enabling users of these therapy machines to prepare, deliver and record treatments via MOSAIQ. The Xstrahl family of treatment systems treats superficial tumors and benign lesions (e.g., basal cell and squamous cell carcinomas, keloid scars and dermatological conditions) with low-energy radiation.Atlanta, GA United States — Sunday, March 27, 2011
The two first users of the MOSAIQ interface have reported success at their institutions, Sequoia Hospital (Redwood City, Calif.) and St. James’s University Hospital (Leeds, U.K.).
“MOSAIQ 2.20 is recording and verifying the treatments we’re giving patients, which is very important to us,” says Helen Monk, Manager, Radiation Oncology at Sequoia Hospital, a MOSAIQ user for more than a decade. “MOSAIQ helps ensure that every step we’re taking is correct. If a setting or filter has somehow been set incorrectly on the Xstrahl system, the machine will not turn on because it does not match what we set in MOSAIQ. If you’re working by yourself, it’s nice to have that added comfort knowing that MOSAIQ is double-checking everything you do to ensure safety.”
St. James’s University Hospital’s Peter Enever, Advanced Practitioner, concurs with Monk regarding the added assurance of safety that the new interface brings.
“You can’t get the combination of filters and applicators wrong,” he says. “The intelligent ‘engine’ in MOSAIQ automatically drives the workflow and checks that each step has been done correctly. From our point of view that is a very good safety feature and it gives users added confidence in what they’re doing.”
Enever adds that MOSAIQ interface’s similarity to that of a linear accelerator made training literally a five-minute process. “It looks and behaves exactly the same way as a linac interface,” he observes.
St. James’s has been moving steadily to a centralized patient record and the addition of the MOSAIQ interface to Xstrahl supports that effort.
“St. James’s Institute of Oncology’s aspiration to achieve a single integrated patient pathway has moved one step closer with the introduction of the MOSAIQ-Xstrahl interface,” Enever says.
*MOSAIQ® is a registered trademark of its manufacturer, IMPAC Medical Systems, Inc. SEQUENCER is MOSAIQ’s verify and record module.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Time zone: CET: Central European
Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Time zone: EDT: Eastern Daylight Time